Company: EVLVW
Filing Date: 2025-05-15
Form Type: NT 10-Q
Source: 0001104659-25-049608
Chunk: 3

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-05-15
Form: NT 10-Q
Chunk 3
---
, on
a preliminary unaudited basis, the Company expects operating loss to be between $15.0 million and $17.0 million. For the quarter ended March 31,
2024, operating loss was $21.9 million.

For the quarter ended March 31, 2025, on
a preliminary unaudited basis, the Company expects net loss to be between $2.5 million and $4.5 million. For the quarter ended March 31, 2024,
net loss was $11.3 million.

As of March 31, 2025, on a preliminary unaudited basis, we estimate total cash, cash equivalents and marketable securities to be $35.0
million, with no outstanding debt, consistent with prior disclosures by the Company.

The foregoing financial information is preliminary and unaudited and
is subject to change. Actual results may vary when reported on the Company’s Q1 2025 Form 10-Q and the changes could be material.

Cautionary Note Regarding Forward-Looking Statements

This Form 12b-25 contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company intends for such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding the completion of matters necessary to permit the filing of the Q1 2025 Form 10-Q andthe anticipated timing
of the filing of the Q1 2025 Form 10-Q. Forward-looking statements involve known and unknown risks, uncertainties and other
important factors that may cause the Company’s actual results and actions to be materially different from any future results
or actions expressed or implied by the forward-looking statements, including, but not limited to, amount of insurance
reimbursements expected to be received for defense costs for counsel and consultants in connection with securities litigation and
related Securities and Exchange Commission (the “SEC”) and Department of Justice matters, and the factors discussed
under the caption “Risk Factors” in the 2024 Form 10-K, as any such factors may be updated from time to time in the
Company’s other filings with the SEC. The forward-looking statements in this Form 12b-25 are based upon information
available to us as